ArticleBMJ open2017
Acceptability of the Cytosponge procedure for detecting Barrett's oesophagus: a qualitative study.
Article in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 38 citations in OpenAlex.
- Trial
- Barriers and Enablers to Capsule Sponge Screening Among People With Heartburn: A Community-Based Qualitative Study in the UK.Health expectations : an international journal of public participation in health care and health policy · 2026Article
- Using a mobile unit to deliver capsule sponge testing for Barrett's oesophagus in the community in England through GP invitation and self-referral: an implementation study.BMJ open gastroenterology · 2026Article
- Use of a Non-Endoscopic Capsule-Sponge Triage Test for Reflux Symptoms: Results From the NHS England Prospective Real-World Evaluation.Alimentary pharmacology & therapeutics · 2025Article
- Review
- Patient experiences of Cytosponge: a qualitative study.Frontline gastroenterology · 2024Article
- Dutch individuals' views of screening for oesophageal cancer: a focus group study.BMJ open gastroenterology · 2023Article
- Development of a Hot-Melt-Extrusion-Based Spinning Process to Produce Pharmaceutical Fibers and Yarns.Pharmaceutics · 2022Article
- Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial.BMJ open · 2022Article
- Public acceptance and uptake of oesophageal adenocarcinoma screening strategies: A mixed-methods systematic review.EClinicalMedicine · 2022Article
- COVID-19: Effect on gastroenterology and hepatology service provision and training: Lessons learnt and planning for the future.World journal of gastroenterology · 2021Review
- Challenges in Determining the Role of Microbiome Evolution in Barrett's Esophagus and Progression to Esophageal Adenocarcinoma.Microorganisms · 2021Review
- Functionality and Acceptance of the EsoCap System-A Novel Film-Based Drug Delivery Technology: Results of an In Vivo Study.Pharmaceutics · 2021Article
- Triage-driven diagnosis of Barrett's esophagus for early detection of esophageal adenocarcinoma using deep learning.Nature medicine · 2021Article
- Public Preferences and Predicted Uptake for Esophageal Cancer Screening Strategies: A Labeled Discrete Choice Experiment.Clinical and translational gastroenterology · 2020Article
- Risk Prediction Models for Barrett's Esophagus Discriminate Well and Are Generalizable in an External Validation Study.Digestive diseases and sciences · 2020Article
- Novel Screening Tests for Barrett's Esophagus.Current gastroenterology reports · 2019Review
- Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2019Article
- A crosssectional analysis of Facebook comments to study public perception of a new diagnostic test called the Cytosponge.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2019Article
- Barrett's esophagus: novel strategies for screening and surveillance.Therapeutic advances in chronic disease · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
Abstract
objectiveTo investigate the acceptability of the Cytosponge, a novel sampling device to detect Barrett's oesophagus (BE), a precursor to oesophageal adenocarcinoma (EAC), among people with risk factors for this condition.
designA qualitative study using semistructured interviews and focus group discussions. Data were explored by three researchers using thematic analysis.
settingCommunity setting in London, UK.
participantsA recruitment company identified 33 adults (17 men, 16 women) aged 50-69 years with gastro-oesophageal reflux disease (GERD), a risk factor for BE. The majority of participants were white British (73%). The focus groups were stratified by gender and education. 10 individuals were interviewed and 23 participated in four focus groups.
results3 key themes emerged from the data: the anticipated physical experience, preferences for the content of information materials and comparisons with the current gold-standard test. Overall acceptability was high, but there was initial concern about the physical experience of taking the test, including swallowing and extracting the Cytosponge. These worries were reduced after handling the device and a video demonstration of the procedure. Knowledge of the relationship between GERD, BE and EAC was poor, and some suggested they would prefer not to know about the link when being offered the Cytosponge. Participants perceived the Cytosponge to be more comfortable, practical and economical than endoscopy.
conclusionsThese qualitative data suggest the Cytosponge was acceptable to the majority of participants with risk factors for BE, and could be used as a first-line test to investigate GERD symptoms. Concerns about the physical experience of the test were alleviated through multimedia resources. The development of patient information materials is an important next step to ensuring patients are adequately informed and reassured about the procedure. Patient stakeholders should be involved in this process to ensure their concerns and preferences are considered. TRIAL REGISTRATION NUMBER: ISRCTN68382401; pre-results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.